Domestically, markets reacted positively to better global indicators, with Indian equities marking their third consecutive session of gains and closing near the day’s peak, propelled by banking stocks. Finance Minister Sitharaman characterized the West Asia conflict as a “systemic tremor,” emphasizing India’s comparatively robust macroeconomic position.
In corporate news, shares of Wipro rose following an eight-year agreement with Olam Group, and HDFC Bank unveiled updates to its credit card reward programs, aligning benefits more closely with spending patterns.
Legally, the Supreme Court declined to stay Adani Enterprises’ resolution plan for Jaiprakash Associates, presenting a challenge for Vedanta. Additionally, the SC mandated a CBI investigation into contracts associated with Arunachal Pradesh Chief Minister Pema Khandu’s family. In the pharmaceutical sector, OneSource Specialty Pharma highlighted the increasing global demand for semaglutide, with expectations that Canada will lead in volumes.
Trump sets ‘final’ Tuesday deadline for Iran, says proposal ‘not good enough’
US President Donald Trump stated on Monday that the Tuesday deadline he established for Iran to finalize an agreement is “final,” signaling a tougher stance from Washington in the ongoing negotiations regarding Tehran’s nuclear program.
Read More Here
ALSO READ: Trump’s F bomb leads to US lawmakers seeking his removal under 25th Amendment
Israel strikes Iran’s petrochemical complex at Asaluyeh, defence minister says
Representative Image
On Monday, April 6, Israel targeted Iran’s largest petrochemical facility at Asaluyeh, described by Defence Minister Israel Katz as a severe economic blow to Tehran.
Read More Here
Markets end near day’s high; bank stocks power Nifty above 22,950
Indian equity markets achieved their third consecutive winning session, rebounding sharply and closing near the day’s high, amidst favorable global indicators linked to West Asia developments.
Read More Here
Also Read: WTI Crude continues to trade at a premium to Brent as Trump deadline on Iran nears
West Asia conflict has escalated into a ‘systemic tremor,’ says FM
Finance Minister Nirmala Sitharaman remarked that the escalation of the West Asia conflict has transitioned from a regional issue to a broader global risk, cautioning about its implications on energy markets and the global order.
Read More Here
Wipro shares rise after bagging eight-year Olam deal worth over $1 billion
Wipro Ltd. shares experienced gains of up to 3% on Monday, April 6, following the company’s acquisition of a long-term transformation deal with Olam Group.
Read More Here
Supreme Court refuses to stay Adani’s JAL resolution plan in setback for Vedanta
On Monday, the Supreme Court of India declined to halt the execution of Adani Enterprises Ltd’s resolution plan for Jaiprakash Associates Ltd, while introducing a safeguard amid Vedanta Ltd.’s challenge.
Read More Here
SC orders CBI inquiry into contracts linked to Arunachal CM Pema Khandu’s family
The Supreme Court has instructed the Central Bureau of Investigation (CBI) to conduct a preliminary inquiry regarding allegations that government contracts in Arunachal Pradesh were awarded to companies associated with Chief Minister Pema Khandu’s relatives.
Read More Here
Delhi HC stays Centre’s order, directs for restoring of Prateek Sharma’s account on X
Delhi High Court on Monday (April 6) put a hold on the government’s order to block the entire account of influencer and commentator Prateek Sharma, known as Dr. Nimo Yadav on X.
Read More Here
HDFC Bank to cut rewards from May; link lounge access to spends from July on select credit cards
HDFC Bank is poised to implement a series of adjustments to its Regalia Gold and Diners Privilege credit cards in the upcoming months, tightening some existing benefits while introducing new travel-related features. These changes, effective May 15 and July 1, reflect a shift towards rewards driven by spending and conditional perks.
Read More Here
OneSource Specialty sees Canada leading semaglutide volumes; Brazil, Turkey next
Neeraj Sharma, MD & CEO of OneSource Specialty Pharma, indicated that global demand for semaglutide is increasing following patent expiration, with several markets such as Canada, Brazil, and Turkey emerging. The company is preparing inventory ahead of approvals and supplying partners like Dr Reddy’s. While Canada is expected to drive the largest volumes, pricing will be linked to volume rather than geography as launches spread across different regions.
Read More Here
We’ll see you on Tuesday with another engaging ‘Top 10@10’
